{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T19:19:28Z","timestamp":1773515968410,"version":"3.50.1"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:p>OBJECTIVE: To compare the immunogenicity of three yellow fever vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots). METHODS: An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types (double-blind). Neutralizing yellow fever antibody titters were compared in pre- and post-immunization serum samples. Equivalence was defined as a difference of no more than five percentage points in seroconversion rates, and ratio between Geometric Mean Titters (GMT) higher than 0.67. RESULTS: Seroconversion rates were 98% or higher among subjects previously seronegative, and 90% or more of the total cohort of vaccinees, including those previously seropositive. Differences in seroconversion ranged from -0.05% to -3.02%. The intensity of the immune response was also very similar across vaccines: 14.5 to 18.6 IU\/mL. GMT ratios ranged from 0.78 to 0.93. Taking the placebo group into account, the vaccines explained 93% of seroconversion. Viremia was detected in 2.7% of vaccinated subjects from Day 3 to Day 7. CONCLUSIONS: The equivalent immunogenicity of yellow fever vaccines from the 17D and 17DD substrains was demonstrated for the first time in placebo-controlled double-blind randomized trial. The study completed the clinical validation process of a new vaccine seed-lot, provided evidence for use of alternative attenuated virus substrains in vaccine production for a major manufacturer, and for the utilization of the 17DD vaccine in other countries.<\/jats:p>","DOI":"10.1590\/s0034-89102004000500009","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T14:29:49Z","timestamp":1114612189000},"page":"671-678","source":"Crossref","is-referenced-by-count":71,"title":["Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial"],"prefix":"10.1590","volume":"38","author":[{"given":"Luiz Antonio Bastos","family":"Camacho","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos da Silva","family":"Freire","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria da Luz Fernandes","family":"Leal","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savitri Gomes de","family":"Aguiar","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussara Pereira do","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 de Azevedo","family":"Lozana","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Henrique Guedes","family":"Farias","sequence":"additional","affiliation":[{"name":"Instituto de Biologia do Ex\u00e9rcito, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Statistical methods in medical research","author":"Armitage P","year":"1994","edition":"3"},{"key":"ref2","series-title":"Encyclopedia of statistics","first-page":"49","volume-title":"Attributable fraction in exposed","author":"Benichou J","year":"1998"},{"key":"ref3","series-title":"Encyclopedia of statistics","first-page":"1367","volume-title":"Equivalence trials","author":"Blackwelder WC","year":"1998"},{"key":"ref4","series-title":"Yellow fever vaccination","first-page":"205","volume-title":"International regulation of yellow fever vaccination","author":"Bonnel PH","year":"1956"},{"key":"ref5","first-page":"113","article-title":"A simple microculture method for the study of group B arboviruses","volume":"40","author":"De Madrid AT","year":"1969","journal-title":"Bull World Health Organ","ISSN":"https:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"dos Santos CN","year":"1995","journal-title":"Virus Res","ISSN":"https:\/\/id.crossref.org\/issn\/0168-1702","issn-type":"print"},{"key":"ref7","series-title":"The design and analysis of clinical experiments","author":"Fleiss JL","year":"1986"},{"key":"ref8","series-title":"Vaccines","first-page":"741","volume-title":"Yellow fever vaccine","author":"Freestone DS","year":"1994","edition":"2"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.2001.1168","article-title":"Phenotypic and a molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil","volume":"290","author":"Galler R","year":"2001","journal-title":"Virology","ISSN":"https:\/\/id.crossref.org\/issn\/0042-6822","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1590\/S1020-49891997000800004","article-title":"Efetividade da vacina antiamar\u00edlica17D: uma avalia\u00e7\u00e3o epidemiol\u00f3gica em servi\u00e7os e sa\u00fade","volume":"2","author":"Guerra HL","year":"1997","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/JVI.77.2.1105-1111.2003","article-title":"Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigations of transmission to vaccine recipients","volume":"77","author":"Hussain AI","year":"2003","journal-title":"J Virol","ISSN":"https:\/\/id.crossref.org\/issn\/0022-538X","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4269\/ajtmh.1999.60.1045","article-title":"Comparison of the immunogenicity and safery fo two 17D yellow fever vaccines","volume":"60","author":"Lang J","year":"1999","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-1157(88)90034-0","article-title":"Studies on yellow fever vaccine: III-Dose response in volunteers","volume":"16","author":"Lopes OS","year":"1988","journal-title":"J Biol Stand","ISSN":"https:\/\/id.crossref.org\/issn\/0092-1157","issn-type":"print"},{"key":"ref14","series-title":"Manual de procedimentos para vacina\u00e7\u00e3o","year":"1994","edition":"3"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and IF-Vax) in a Phase III Multicenter, double-blind clinical trial","volume":"66","author":"Monath TP","year":"2002","journal-title":"Am J Trop Med Hyg","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9637","issn-type":"print"},{"key":"ref16","series-title":"Vaccines","first-page":"815","volume-title":"Yellow fever","author":"Monath TP","year":"1999","edition":"3"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig M","year":"1999","journal-title":"Trop Med Int Health","ISSN":"https:\/\/id.crossref.org\/issn\/1360-2276","issn-type":"print"},{"key":"ref18","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland JD","year":"1981","journal-title":"Bull World Health Organ","ISSN":"https:\/\/id.crossref.org\/issn\/0042-9686","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1542\/peds.96.3.600","article-title":"The reverse cumulative distribution plot: a graphic method of exploratory analysis of antibody data","volume":"96","author":"Reed GF","year":"1995","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0264-410X(86)90004-6","article-title":"Comparative clinical study of a new 17D thermostable yellow fever vaccine","volume":"4","author":"Roche JC","year":"1986","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the efficacy of yellow fever vaccine","volume":"17","author":"Stefano I","year":"1999","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/infdis\/126.4.362","article-title":"Effect of interval between inoculation of live smallpox and yellow-fever vaccines on antigenicity in man","volume":"126","author":"Tauraso NM","year":"1972","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref23","series-title":"WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases","year":"2000"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-1157(86)90016-8","article-title":"Evaluation du vaccin antiamaril thermostable de l'Institut Pasteur chez des voyageurs internationaux","volume":"14","author":"Wolga J","year":"1986","journal-title":"J Biol Stand","ISSN":"https:\/\/id.crossref.org\/issn\/0092-1157","issn-type":"print"},{"key":"ref25","series-title":"Yellow fever: technical consensus meeting","year":"1998"}],"container-title":["Revista de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsp\/v38n5\/21755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T22:45:56Z","timestamp":1735685156000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89102004000500009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0034-89102004000500009"],"URL":"https:\/\/doi.org\/10.1590\/s0034-89102004000500009","relation":{},"ISSN":["0034-8910"],"issn-type":[{"value":"0034-8910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}